Most Popular Stories
- GSK, Takeda say nay to in-house diagnostics units
- EMC to found Russian cloud computing, 'Big Data' hub
- Being more like Coca-Cola takes days out of GSK's pharma supply chain
- Merck says Victrelis can interfere with HIV meds
- WellPoint to drop branded Lipitor from its formulary
- Psychologists petition against DSM-5 revisions
Webinars
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
Featured Jobs
-
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Sr. Director, Alliance Management Job
Celgene Corporation - Summit, NJ, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ
Popular Topics
Events
- CALBIO2012: Driven By Patients - Marriott Marquis
March 8-9 — San Francisco, CA - DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida - Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York
Carl Icahn
Related Stories
- George Scangos - The 25 most influential people in biopharma today
- Alex Denner - The 25 most influential people in biopharma today
- Can Denner's new hedge fund replicate Icahn's golden biotech touch?
- Icahn biotech whiz Denner jumps ship after 5 turbulent years
- Icahn-backed Enzon Pharma axing half of workforce
Tools

More stories about Carl Icahn


SHARE
WITH: